Intelis Capital

Dynamhex monitors and visualizes complex energy consumption data for individual, corporate and government entities. By linking to science-based emission reduction targets, Dynamhex allows climate leaders to make data-driven decisions in a timely fight against climate change.

Geosite is a business operations platform that links the power of spatial data and analytics to business operations, incident management, and planning workflows.

Amperon is a provider of smart meters to deliver real-time energy data forecasts. There over 70M smart meters currently installed in the country, collecting 15 minute resolution electricity data for every type of ratepayer (including residential, commercial, and industrial). The data has been relatively untapped for the past decade, and Amperon is leveraging it to charge forward and bring AI to the energy world to usher in the smart grid of the future.

Digital transformation that starts with people Does the new digital age of work have your team struggling with crossed wires and missed opportunities? You're not alone. If technology doesn't serve your processes, it won't serve your people. That's why WNDYR is more than just a team of Adobe-certified experts. From process design to platform integration and automation to organizational change management, our people-first solutions bring both immediate impact and lasting transformation.

Digital transformation that starts with people Does the new digital age of work have your team struggling with crossed wires and missed opportunities? You're not alone. If technology doesn't serve your processes, it won't serve your people. That's why WNDYR is more than just a team of Adobe-certified experts. From process design to platform integration and automation to organizational change management, our people-first solutions bring both immediate impact and lasting transformation.

We are technology company building a world where the way we work, move, and live is powered by clean energy. Our marketplace helps clean energy developers contract quickly with pre-vetted landowners, energy offtakers, and financiers. Developers build these listings into de-risked projects that deliver clean energy to communities. Using digital land asset valuation technology and integrated DNV digital services, our technology builds trust with landowners and allows them to list the lowest risk and fastest-to-close land deals.The data-driven marketplace ensures that developers add land to their portfolios that has energy offtake and financing packaged where possible to accelerate the way we decarbonize the grid with clean energy projects. Headquartered in the San Francisco Bay Area, HST’s diverse team collectively brings several decades worth of clean energy and software experience. We work collaboratively to reinvent the way we decarbonize this planet.

BioLum Sciences specializes in bioanalytical chemistry & medical device development centered around our core analysis platform and chemiluminescent chemistry. BioLum uses advanced chemical systems to measure biomarkers in exhaled breath condensate and blood samples. This technology empowers pharmaceutical researchers and clinicians with tools to develop and personalize treatments for patients with chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure. We have several medical device products in the pipeline and offer our research & development expertise in assay development and clinical biomarker measurement, with an emphasis on oxidative stress and nitric oxide signaling. With the advent of biomarker analysis for monitoring disease severity and progression (airway inflammation, lung function) there is a desire to shift towards remote patient monitoring via non-invasive biomarkers to improve treatment plans and lower overall costs on the healthcare system. Our initial programs are focused on asthma, COPD, and hypertension. Our breath analysis product, The BioSense AMD (Airway Monitoring Device), provides a ‘window into the lung’ by measuring oxidative stress biomarkers in exhaled breath condensate (EBC). Our test requires no complicated breathing maneuvers, allowing reliable at-home monitoring. These frequent, objective measurements of lung function offer significant patient benefits, provide physicians a tool to optimize treatment, and enable researchers to stratify patients in clinical trials to better understand chronic respiratory disease states. Our blood analysis product measures nitric oxide and nitrative stress metabolites in the blood using a simple finger-prick test. This point-of-care device will provide physicians, researchers, and patients with a critical gauge of endothelial function and cardiovascular health.